ARCHIVES

FDA Grants Orphan Designation To Photofrin for Mesothelioma

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

RFA Announcement On Carcinogenesis Extrapolation

August 1, 1980

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

NCI Community Intervention Trial Reports

March 10, 1995

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

Senate Passes Non-Binding Resolution To Double NIH Budget Over Five Years

May 23, 1997

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987